A Randomized, Open-label, Multiple-dose, Two-sequence, Two-period Crossover Study to Investigate The Pharmacokinetics Between a GL2907 and Oxycontin CR Tab. 10mg in Healthy Male Volunteers

This study is not yet open for participant recruitment.
Verified February 2013 by GL Pharm Tech Corporation
Sponsor:
Information provided by (Responsible Party):
GL Pharm Tech Corporation
ClinicalTrials.gov Identifier:
NCT01779492
First received: January 28, 2013
Last updated: February 18, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: May 2013
  Estimated Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)